Gilead Sciences, Inc.
18 drugs in NADAC|0 Generic,18 Brand
View Recalls (7)Gilead Sciences, Inc. lists 18 NDCs in the CMS NADAC file (0 generic, 18 brand), at an average NADAC of $285.92 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
18
0G / 18B
Avg Price / Unit
$285.9225
$17.45 – $1098.94
Avg 7d Change
-0.01%
Across 8 drugs with changes
7d Activity
of 18 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Gilead Sciences, Inc. make?
Gilead Sciences, Inc. lists 18 NDCs in the CMS NADAC file — 0 generic and 18 brand products.
What is the average price of Gilead Sciences, Inc. drugs?
The average NADAC across Gilead Sciences, Inc.'s portfolio is $285.9225 per unit, ranging from $17.4459 to $1098.9375.
What types of drugs does Gilead Sciences, Inc. make?
Gilead Sciences, Inc. makes drugs across 8 FDA pharmacologic classes. The most common by NDC count are Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor (25), Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor (13), Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor (4), Hepatitis C Virus NS5A Inhibitor (3), Cytochrome P450 3A Inhibitor (2).
Has Gilead Sciences, Inc. had any drug recalls?
7 FDA recalls are matched to Gilead Sciences, Inc. in the openFDA feed, most recently on Sep 19, 2024.
How has Gilead Sciences, Inc.'s pricing changed recently?
Over the past 7 days, 5 Gilead Sciences, Inc. products rose and 3 fell, with a portfolio-wide average change of -0.0%.
FDA Recalls (7)
Recalls matched by company name. Verify current status with FDA.
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Presence of Particulate Matter: Presence of glass particle.
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foster City, CA NDC 61958-0602-1 Gilead Sciences, Inc. Foster City, CA 94404.
Defective Container; leaking around the cap
Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1
Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland
Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.
AmBisome (amphotericin B) liposome for Injection, 50 mg, For Intravenous Infusion Only, Single-Use Vial, Rx Only, Marketed by: Astellas Pharma US, Inc., Northbrook, IL 60062, Manufactured by: Gilead Sciences, Inc., San Dimas, CA 91773, NDC 0469-3051-30.
Lack of Sterility Assurance; During a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in some media fill units. No contaminated batches have actually been identified in the finished product, but there is a possibility of contamination.
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.
Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).